Progyny forecasts 2026 revenue of $1.36B-$1.385B while targeting 1M+ new lives
Progyny (PGNY) forecasts revenue of $1.36 billion to $1.385 billion for 2026 and aims to secure over 1 million new subscribers.
The current price of $30.21 is positioned above the support level of $29.93; however, due to a -0.7% bearish trend over the past 7 days and a trading volume that is 0.61 times lower than the 20-day average, the potential for a rebound has weakened.
Based on the current price of $30.21, if it holds the support level of $29.93 and rebounds, the target for taking profits is $33.06 (resistance level). Conversely, if the bearish trend continues and it falls below the stop-loss level of $29.93, a stop-loss response will be implemented.
The RSI(14) is 45.6, the moving averages are in a positive alignment, the trading volume is 0.61 times the 20-day average, and the recent 7-day volatility is recorded at -0.7%.
At the time of entry, the current price of $30.21 was positioned above the support level of $29.93; however, due to a -0.7% bearish trend over the past 7 days and a trading volume that was 0.61 times lower than the 20-day average, the rebound strength was weakened. Despite the positive guidance regarding the 2026 revenue outlook and new subscriber targets, it failed to overcome the low trading volume and bearish momentum, ultimately breaching the stop-loss level and resulting in an actual outcome of -14.9%, classified as FAILED.
In future trading, even if there are positive news or guidance announcements, we will reflect a more conservative approach to entry or apply stricter stop-loss criteria, as the trading volume is significantly below the 20-day average (0.61 times) and the recent volatility has recorded a negative (-) trend, indicating a weakening momentum.